AVENZOAR PHARMACEUTICALS
Avenzoar Pharmaceuticals operates as a start-up pharmaceutical company. It specializes in developing cancer drugs targeting and inhibiting mechanisms of metastasis and drug resistance. The company has three drugs in the pipeline so far. The drug is AP-001 (aka Metavert), which is expected to be tested in pancreatic cancer patients in 2024/2025.
AVENZOAR PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2016-01-01
Address:
Encinitas, California, United States
Country:
United States
Website Url:
http://www.avenzoarpharmaceuticals.com
Status:
Active
Contact:
310-502-0770
Technology used in webpage:
Google Google Cloud Wix
Similar Organizations
Addpharma
Addpharma is a pharmaceuticals company that develops Incrementally Modified Drugs (IMDs).
Boston Biopharma
Boston Biopharma specializes in the development and distribution of a wide array of pharmaceutical products globally.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Laurent Pharmaceuticals
Laurent Pharmaceuticals is a private biopharmaceutical company developing a clinical stage, orally-active drug candidate.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
New River Pharmaceuticals Inc
New River Pharmaceuticals is a specialty pharmaceutical company developing novel pharmaceuticals.
Peroxitech Therapeutics
Peroxitech Therapeutics operates as a biopharmaceutical company.
Tivorsan Pharmaceuticals
Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.
Current Employees Featured
Mouad Edderkaoui Founder & Chief Scientific Officer @ Avenzoar Pharmaceuticals
Founder & Chief Scientific Officer
Terrance Bruggeman CEO @ Avenzoar Pharmaceuticals
CEO
2016-02-01
Founder
Official Site Inspections
http://www.avenzoarpharmaceuticals.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109

More informations about "Avenzoar Pharmaceuticals"
Avenzoar – Committed to the fight against cancer
Our leading investigational drug represents a significant advancement in the treatment of cancer. AP-001 has shown promising results in preclinical studies and is expected to undergo rigorous clinical trials to demonstrate its efficacy …See details»
About - Avenzoar
Shierley Widjaja has served on Avenzoar’s Board of Directors since 2023. She has an impressive background in the biotech and pharmaceutical industries, and serves as a Director at …See details»
Avenzoar Pharmaceuticals - Crunchbase Company …
Avenzoar Pharmaceuticals is a pharmaceutical company developing cancer drugs. Avenzoar Pharmaceuticals operates as a start-up pharmaceutical …See details»
Avenzoar - Company Profile - Tracxn
Jan 14, 2025 Avenzoar Pharmaceuticals develops drugs for treating cancer by inhibiting the pathways involved in cancer metastasis and drug resistance. The lead candidate is AP-001 …See details»
Avenzoar Pharmaceuticals, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Avenzoar Pharmaceuticals, Inc. of Encinitas, CA. Get the latest business insights from Dun & Bradstreet.See details»
Avenzoar Pharmaceuticals, Inc. - VentureRadar
Website: https://www.avenzoarpharmaceuticals.com/ Develops cancer drugs aimed at inhibiting metastasis and drug resistance, with three drugs in pipeline and trials ...See details»
Avenzoar Pharmaceuticals, Inc. - Corporation Wiki
Avenzoar Pharmaceuticals, Inc. Overview. Avenzoar Pharmaceuticals, Inc. filed as a Articles of Incorporation in the State of California on Tuesday, October 13, 2015 and is approximately …See details»
Avenzoar Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Explore Avenzoar Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
AVENZOAR PHARMACEUTICALS INC Encinitas CA, 92024 - Cortera
Free Business profile for AVENZOAR PHARMACEUTICALS INC at 662 Encinitas Blvd, Encinitas, CA, 92024-6792, US. AVENZOAR PHARMACEUTICALS INC specializes in: Drugs, Drug …See details»
Avenzoar Pharmaceuticals - Overview, News & Similar companies ...
View Avenzoar Pharmaceuticals (www.avenzoarpharmaceuticals.com) location in California, United States , revenue, industry and description. Find related and similar companies as well …See details»
Avenzoar Pharmaceuticals - Products, Competitors, Financials, …
Avenzoar Pharmaceuticals is a start-up pharmaceutical company focused on developing cancer drugs within the healthcare sector. Use the CB Insights Platform to explore Avenzoar …See details»
About - Avenzoar
Avenzoar Pharmaceuticals is a research-focused biotechnology company dedicated to the discovery and development of innovative cancer therapies.See details»
Management Team - Avenzoar
Stephen Thesing serves as the Chief Executive Officer of Avenzoar Pharmaceuticals, bringing over a decade of leadership and business development experience in the life sciences industry.See details»
Avenzoar Pharmaceuticals Company Profile | Management and
Find contact information for Avenzoar Pharmaceuticals. Learn about their Manufacturing market share, competitors, and Avenzoar Pharmaceuticals's email format.See details»
Avenzoar Pharmaceuticals - PitchBook
Avenzoar Pharmaceuticals General Information Description. Operator of a pharmaceutical company intended to develop small molecule therapeutics that simultaneously target multiple …See details»
Avenzoar Pharmaceuticals - Contacts, Employees, Board Members, …
Avenzoar Pharmaceuticals is a pharmaceutical company developing cancer drugs. Experience the new Crunchbase, powered by AISee details»
Avenzoar Pharmaceuticals Stock Price, Funding, Valuation, …
Jun 16, 2023 avenzoarpharmaceuticals.com. Overview & Products; Financials; People; Total Raised $1.43M. Funding, Valuation & Revenue. 2 Fundings. Avenzoar Pharmaceuticals has …See details»
Pharmaceutical Startup Will Test Novel Drug Treatment for …
Oct 8, 2019 InteliSpark client, Avenzoar Pharmaceuticals , wins a research grant from the National Institutes of Health (NIH) to develop a new drug for the treatment of pancreatic …See details»
Novartis receives FDA accelerated approval for Vanrafia® …
1 day ago Ad hoc announcement pursuant to Art. 53 LR. Vanrafia can be seamlessly added to supportive care in IgAN and used as a foundational therapy with no requirement for a REMS …See details»
Research& Development - Avenzoar
Our research and development efforts are focused on discovering and developing innovative oncology treatments. Our approach is rooted in scientific excellence and a deep understanding …See details»